Jiaxing, China · Founded 2018 · Privately Held (backing)
Developer of drugs designed for respiratory anti-infection. AnDiConBio is based in Jiaxing, China and was founded in 2018. It has raised $43.4 million.
Last price · $/share
—
Implied valuation
—
Total raised
$43.4M
Last round
—
How much has AnDiConBio raised?
$43.4Macross 0 recorded rounds
Free account
More of AnDiConBio with a free account
·The complete investor list: 15 names
·Watch AnDiConBio: the Monday email on marks, rounds and moves